IL17A and candidiasis: Studies of patients with CMC have revealed that interleukin (IL)-17 immunity, which involves T helper 17 (Th17) cells and IL-17 signaling, plays a pivotal role in immune defense against mucocutaneous Candida infections in humans (3, 5).